Related Experiment Video
Updated: Mar 7, 2026

07:59
Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
Published on: July 21, 2017
10.1K
Injection Adipolysis: Mechanisms, Agents, and Future Directions
Shahraam Kamalpour1, Keith Leblanc2
1Louisiana State University Dermatology, New Orleans, Louisiana.
The Journal of Clinical and Aesthetic Dermatology
|February 18, 2017
Summary
Injection adipolysis uses sodium deoxycholate injections to reduce unwanted fat. While effective for submental fat, combining it with phosphatidylcholine may improve cosmetic results and reduce side effects.
Area of Science:
- Dermatology
- Cosmetic Science
- Pharmacology
Background:
- Noninvasive methods for adipose tissue reduction are emerging.
- Injection adipolysis involves injecting cytotoxic agents to reduce fat volume for cosmetic purposes.
Purpose of the Study:
- To review the development and efficacy of injection adipolysis, focusing on sodium deoxycholate.
- To explore the potential benefits of combining sodium deoxycholate with phosphatidylcholine.
Main Methods:
- Review of existing research on injection adipolysis agents.
- Analysis of the mechanism of action of sodium deoxycholate on adipose tissue.
- Examination of FDA approval and clinical outcomes for submental fat treatment.
Main Results:
- Sodium deoxycholate is approved for submental fat reduction, showing moderate efficacy and patient satisfaction.
- In vitro studies confirm sodium deoxycholate's ability to induce adipocyte lysis.
- Phosphatidylcholine may enhance cosmetic outcomes and reduce injection site reactions.
Conclusions:
- Subcutaneous sodium deoxycholate injections offer a noninvasive option for aesthetic fat reduction.
- Future research may focus on combination therapies for improved cosmetic results and tolerability in injection adipolysis.
Related Concept Videos
Overview of Lipid Metabolism
6.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.3K
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Lipid Catabolism
1.2K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.2K
Lipid Digestion
101.3K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
101.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K

